Clinical Trials Sponsored by Innate Immunotherapeutics
Total 587 results
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical TrialsCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisNew Zealand
-
OSE ImmunotherapeuticsRecruitingCoronavirus Disease (COVID-19)Belgium
-
Avant ImmunotherapeuticsCompletedMyocardial Ischemia | Mitral Valve Insufficiency | Aortic Valve Insufficiency | Coronary ArteriosclerosisUnited States
-
Alladapt Immunotherapeutics, Inc.Terminated
-
Alladapt Immunotherapeutics, Inc.Completed
-
OSE ImmunotherapeuticsRecruitingDose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or LymphomasLymphoma | Solid Advanced TumorFrance, Belgium
-
OSE ImmunotherapeuticsRecruitingUlcerative ColitisBelgium, Latvia, Bulgaria, Belarus, Croatia, Georgia, Hungary, Poland, Russian Federation, South Africa, Ukraine
-
OSE ImmunotherapeuticsTerminatedNon Small Cell Lung CancerFrance, Spain, Israel, United States, United Kingdom, Italy, Poland, Czechia, Germany, Hungary
-
OSE ImmunotherapeuticsCompletedRheumatoid Arthritis | Complication of TransplantBelgium
-
Artielle ImmunoTherapeuticsUnknownMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Avant ImmunotherapeuticsCompleted
-
SIRPant Immunotherapeutics, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
Elixiron Immunotherapeutics Inc.Recruiting
-
Brooklyn ImmunoTherapeutics, LLCCompletedSquamous Cell Carcinoma of the Oral CavityUnited States, Brazil, United Kingdom, Canada
-
Heidelberg ImmunoTherapeutics GmbHTerminatedHerpes LabialisGermany
-
RUTI Immunotherapeutics S.L.Completed
-
OSE ImmunotherapeuticsServierCompleted
-
MoonLake Immunotherapeutics AGCompletedArthritis, PsoriaticUnited States, Spain, Bulgaria, Poland, Czechia, Estonia, Germany, Hungary
-
MoonLake Immunotherapeutics AGCompletedHidradenitis SuppurativaGermany, United States, Bulgaria, Canada, Ireland, Netherlands, Poland
-
Heidelberg ImmunoTherapeutics GmbHCompletedHerpes GenitalisGermany
-
Brooklyn ImmunoTherapeutics, LLCCompletedSquamous Cell Carcinoma of the Head and Neck
-
Elixiron Immunotherapeutics Inc.ParexelCompletedHealthy VolunteersUnited States
-
OSE ImmunotherapeuticsBoehringer IngelheimActive, not recruitingSolid Tumor, AdultFrance, Belgium
-
Nantes University HospitalOSE ImmunotherapeuticsActive, not recruitingKidney TransplantationFrance
-
Innate PharmaTerminatedSquamous Cell Carcinoma of the Oral CavityGermany, Spain
-
Innate PharmaCompletedInflammation | Rheumatoid ArthritisGermany
-
GERCOR - Multidisciplinary Oncology Cooperative...OSE ImmunotherapeuticsRecruitingMetastatic Cancer | Pancreatic Ductal Adenocarcinoma | Locally Advanced CancerFrance
-
AIDS Healthcare FoundationHIV Immunotherapeutics InstituteCompletedHIV-1-infection | Gut InflammationUnited States
-
Innate PharmaRecruitingNon Hodgkin LymphomaUnited States, Australia
-
Innate PharmaRecruitingNon Small Cell Lung CancerFrance, United States, Greece, Hungary, Poland
-
Innate PharmaCompleted
-
Innate PharmaCompletedPeripheral T Cell LymphomaKorea, Republic of, United States
-
Innate PharmaActive, not recruitingLymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides/Sezary SyndromeUnited States, Spain, France, Italy, Belgium, Austria, Germany, Poland
-
Innate PharmaCompletedCutaneous T-Cell LymphomaUnited States, France, Netherlands, United Kingdom
-
Innate PharmaTerminatedChronic Lymphocytic LeukemiaUnited States
-
Innate PharmaCompletedAcute Myeloid LeukemiaFrance
-
Innate PharmaCompletedMultiple MyelomaUnited States
-
Innate PharmaCompletedSmoldering Multiple MyelomaUnited States
-
Innate PharmaCompleted
-
Innate PharmaCompletedPatients With Multiple Myeloma Experiencing a | First or Second RelapseUnited States
-
Providence Health & ServicesBrooklyn ImmunoTherapeutics, LLCActive, not recruitingBreast Neoplasm | Triple Negative Breast Cancer | Breast Neoplasm, MaleUnited States
-
AstraZenecaInnate PharmaActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, France, Italy, Spain, Belgium, Canada, Taiwan, Switzerland, Korea, Republic of, Japan, Poland, Russian Federation, United Kingdom, Austria, Brazil, Germany, Netherlands, Portugal, Australia, Philippines, Bulgaria, G... and more
-
Innate PharmaAstraZenecaTerminatedAdvanced Solid TumorsUnited States, France
-
Innate PharmaAstraZenecaCompletedHead and Neck NeoplasmsUnited States, France
-
Kinnate BiopharmaActive, not recruitingIntrahepatic Cholangiocarcinoma | Urothelial Carcinoma | Solid Tumor, AdultUnited States, Korea, Republic of, Taiwan, China, Denmark, Spain
-
Emory UniversityBristol-Myers Squibb; Brooklyn ImmunoTherapeutics, LLCWithdrawnStage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 | Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 | Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma | Stage II Oral Cavity Squamous Cell...United States
-
Institut Paoli-CalmettesInnate PharmaUnknownHematologic MalignanciesFrance
-
Jules Bordet InstituteInnate PharmaWithdrawnAdenocarcinoma of the Gastroesophageal Junction | Squamous Cell Carcinoma of the Esophagus | Adenocarcinoma of the EsophagusBelgium
-
Kinnate BiopharmaRecruitingMelanoma | Non-small Cell Lung Cancer | Solid Tumor, AdultUnited States, Australia, France, Spain, Taiwan, Korea, Republic of, China, Netherlands